Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Sevabertinib

(Synonyms: BAY2927088, BAY 2927088) Copy Product Info
🥰Excellent

Synonyms: BAY2927088, BAY 2927088

Catalog No. T200964 Copy Product Info
Purity: 99.81%
🥰Excellent
Sevabertinib (BAY 2927088) is a selective, potent epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor with anti-tumor activity, used in the study of non-small cell lung cancer.
Sevabertinib
Cas No. 2521285-05-0
TargetMol | Customer service
Customer service consultation
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$64In StockIn Stock
5 mg$156In StockIn Stock
10 mgInquiryIn StockIn Stock
25 mgInquiryIn StockIn Stock
50 mgInquiryInquiryInquiry
100 mgInquiryInquiryInquiry
200 mgInquiryInquiryInquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
With extensive experience in compound synthesis, we can provide rapid custom synthesis services for this product according to your research needs.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.81%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Sevabertinib (BAY 2927088) is a selective, potent epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor with anti-tumor activity, used in the study of non-small cell lung cancer.
SynonymsBAY2927088, BAY 2927088
Chemical Properties
Molecular Weight484.93
FormulaC24H25ClN4O5
Cas No.2521285-05-0
SmilesN(C1=C(NC2=C1C(=O)NCC2)C=3C(OC[C@@H]4COCCO4)=CN=CC3)C5=C(OC)C(Cl)=CC=C5
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 132.5 mg/mL (273.24 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+90% Saline: < 10 mg/mL (20.62 mM), Lower concentrations may be soluble, but exact solubility limit is unknown.
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 10 mg/mL (20.62 mM), Solution.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.0622 mL10.3108 mL20.6215 mL103.1077 mL
5 mM0.4124 mL2.0622 mL4.1243 mL20.6215 mL
10 mM0.2062 mL1.0311 mL2.0622 mL10.3108 mL
20 mM0.1031 mL0.5155 mL1.0311 mL5.1554 mL
50 mM0.0412 mL0.2062 mL0.4124 mL2.0622 mL
100 mM0.0206 mL0.1031 mL0.2062 mL1.0311 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 µL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 µL Tween 80 and mix well until fully clarified.

3) Add 450 µL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
µL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: Sevabertinib chemical structure | Sevabertinib formula | Sevabertinib molecular weight